Depression drug focused GH Research surges 25% in market debut
Imgorthand/E+ via Getty Images
- Shares of depression drug-focused GH Research PLC (NASDAQ:GHRS) have surged more than 25% to $20.10 in afternoon trading, well above its IPO price of $16 per share in its first trading session.
- Shares opened at $22.79 at about…
